• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCICENCS IMPLANTS SA OSVII

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCICENCS IMPLANTS SA OSVII Back to Search Results
Catalog Number XXX- OSVII
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problems Brain Injury (2219); Injury (2348)
Event Type  Injury  
Event Description
The father of the patient contacted directly integra and explained that his daughter got slit ventricle syndrome diagnosis and the osv was switched to another one.The patient has had the osv implanted for two and half years.The slit ventricle syndrome diagnosis appeared in autumn.No other information provided.
 
Manufacturer Narrative
Integra has completed their internal investigation on march 20, 2014.The investigation included: methods: evaluation of actual device, review of device history records, review of complaints history.Results: no device has been returned to integra for analysis.Dhr review; no traceability information was provided, no device history records review could be performed.Complaints history; from january 2013 ¿ march 20, 2017, a total of three (3) complaints (including this one) for osv ii valve systems have been reported for overdrainage.No adverse trend is observed.(b)(4).Conclusion: the exact root cause of the reported overdrainage could not be determined.Valve overdrainage is a known complication of valve therapy, identified in the product risk management and in the device labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OSVII
Type of Device
OSVII
Manufacturer (Section D)
INTEGRA NEUROSCICENCS IMPLANTS SA
2905 route des dolines
2905 route des dolines
sophia antipolis F-069 21
FR  F-06921
Manufacturer (Section G)
INTEGRA NEUROSCICENCS IMPLANTS SA
2905 route des dolines
sophia antipolis F-069 21
FR   F-06921
Manufacturer Contact
rowena bunuan
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key6348995
MDR Text Key67953448
Report Number9612007-2017-00006
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K140722
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberXXX- OSVII
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age6 YR
-
-